CLOAKLINK Trademark

Trademark Overview


On Tuesday, September 12, 2023, a trademark application was filed for CLOAKLINK with the United States Patent and Trademark Office. The USPTO has given the CLOAKLINK trademark a serial number of 98174937. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Tuesday, February 11, 2025. This trademark is owned by Solve Therapeutics, Inc.. The CLOAKLINK trademark is filed in the Pharmaceutical Products category with the following description:

chemical products for medicinal and pharmaceutical use, namely, monoclonal-antibody-drug-conjugate preparations for the treatment of cancer or other indicated human disease; pharmaceutical products for the treatment of cancer, autoimmune diseases, and viral infections; preparations for the medical treatment of cancer consisting of a monoclonal antibody (mAb) or antibody fragment connected to an anti-cancer payload or toxin or immune-stimulant via a chemical linker; chemical reagents for medical use
cloaklink

General Information


Serial Number98174937
Word MarkCLOAKLINK
Filing DateTuesday, September 12, 2023
Status730 - FIRST EXTENSION - GRANTED
Status DateTuesday, February 11, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 18, 2024

Trademark Statements


Goods and Serviceschemical products for medicinal and pharmaceutical use, namely, monoclonal-antibody-drug-conjugate preparations for the treatment of cancer or other indicated human disease; pharmaceutical products for the treatment of cancer, autoimmune diseases, and viral infections; preparations for the medical treatment of cancer consisting of a monoclonal antibody (mAb) or antibody fragment connected to an anti-cancer payload or toxin or immune-stimulant via a chemical linker; chemical reagents for medical use

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, October 2, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSolve Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBelmont, CA 94002

Party NameSolve Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBelmont, CA 94002

Trademark Events


Event DateEvent Description
Friday, September 15, 2023NEW APPLICATION ENTERED
Monday, October 2, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, May 7, 2024ASSIGNED TO EXAMINER
Friday, May 10, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, June 18, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 13, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, May 29, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 18, 2024PUBLISHED FOR OPPOSITION
Tuesday, February 11, 2025SOU TEAS EXTENSION RECEIVED
Tuesday, February 11, 2025SOU EXTENSION 1 FILED
Wednesday, February 12, 2025SOU EXTENSION 1 GRANTED
Wednesday, February 12, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED